
Imagen Bioworks provides an autonomous microscopy platform to speed up biotherapy development. The system combines automation, artificial intelligence, and synthetic biology to analyze biological samples at scale. It is a B2B platform designed for biotech and pharmaceutical researchers. By reimagining microscopy, it aims to cut R&D time and costs by at least 100-fold. Key technologies include automated imaging, AI analysis, and synthetic biology workflows.

Imagen Bioworks provides an autonomous microscopy platform to speed up biotherapy development. The system combines automation, artificial intelligence, and synthetic biology to analyze biological samples at scale. It is a B2B platform designed for biotech and pharmaceutical researchers. By reimagining microscopy, it aims to cut R&D time and costs by at least 100-fold. Key technologies include automated imaging, AI analysis, and synthetic biology workflows.